Cancer Trials - Impower010; Checkmate 816; Drug Dosing; Swiss Edition W/ Timothee Olivier

Cancer trials - IMPOWER010; CheckMate 816; Drug Dosing; Swiss Edition w/ Timothee Olivier

Vinay Prasad MD MPH

Dr. Patrick Forde Discusses 3-Year CheckMate 816 NSCLC Results at ASCO 2023

What happens in every stage of lung cancer? | Cancer: Explained | Macmillan Cancer Support

Macmillan Cancer Support

CheckMate-816: what does the data tell us?

What To Know About Cancer Clinical Trials

Checkmate 816: Combining Chemo and Opdivo - ASCO Lung Review 2022

GRACE - Global Resource for Advancing Cancer Education

Event-free survival results from CheckMate 816

Immunotherapy as combination and neoadjuvant therapies in NSCLC

Surgical outcomes from the Phase III CheckMate 816 trial

Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial

Checkmate 816: Neoadjuvant Nivolumab + Chemotherapy for NSCLC - OncTalk Lung 2023

GRACE - Global Resource for Advancing Cancer Education

POLO trial is back | OS is negative | But the manuscript is full SPIN CYCLE | Insane!

Vinay Prasad MD MPH

CheckMate 816: addressing unanswered questions on surgical outcomes following neoadjuvant chemo-IO

The rationale and trial design of the NADIM II trial

CheckMate 816 trial: Nivolumab + platinum-doublet chemotherapy vs chemo as neoadjuvant treatment...

ASCO 2021 Lung Recap: Surgical Outcomes & Checkmate 816: Nivolumab in Early Stage NSCLC

GRACE - Global Resource for Advancing Cancer Education

IMvigor 210 Results in Metastatic Urothelial Carcinoma

Targeted Oncology

Surgical outcomes from CheckMate 816: NIVO plus chemo vs chemo alone as neoadjuvant treatment fo...

Lung Cancer Clinical Trial Helps Fiona Live Longer | Catalyst

Biomarker testing in gastroesophageal cancer